Weighted Average Number of Shares Outstanding, Basic of Mineralys Therapeutics, Inc. from Q1 2022 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Mineralys Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q1 2022 to Q3 2025.
  • Mineralys Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 70.6M shares, a 41.7% increase year-over-year.
  • Mineralys Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 48.5M shares, a 34.1% increase from 2023.
  • Mineralys Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 36.2M shares, a 600% increase from 2022.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Mineralys Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 70.6M +20.8M +41.7% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 65.5M +16.1M +32.6% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 53.2M +8.26M +18.4% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025
Q4 2024 48.5M +12.4M +34.1% 01 Oct 2024 31 Dec 2024 10-K 12 Feb 2025
Q3 2024 49.8M +9.88M +24.8% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 49.4M +9.6M +24.2% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 44.9M +20.1M +81.3% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025
Q4 2023 36.2M +31M +600% 01 Oct 2023 31 Dec 2023 10-K 12 Feb 2025
Q3 2023 39.9M +34.7M +671% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 39.8M +34.6M +672% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 24.8M +19.6M +383% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 5.17M 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 5.18M 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 5.15M 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 5.12M 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023

Mineralys Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 48.5M +12.4M +34.1% 01 Jan 2024 31 Dec 2024 10-K 12 Feb 2025
2023 36.2M +31M +600% 01 Jan 2023 31 Dec 2023 10-K 12 Feb 2025
2022 5.17M 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.